Literature DB >> 28360217

Bilateral Lung Transplantation for Bleomycin-Associated Lung Injury.

Vivek Narayan1, Charuhas Deshpande2, Christian A Bermudez3, Jaclyn M Golato4, James C Lee5, Joshua Diamond5, David J Vaughn6.   

Abstract

This report details the successful use of bilateral lung transplantation for the management of severe postoperative bleomycin-associated lung injury. This case highlights that the extremely favorable prognosis of advanced testicular germ cell tumors after systemic chemotherapy (>90% cure rate) should not preclude lung transplant consideration in all cases, despite current guidance that considers an advanced malignancy to be a contraindication for lung transplant listing. The Oncologist 2017;22:620-622. © AlphaMed Press 2017.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28360217      PMCID： PMC5423508          DOI： 10.1634/theoncologist.2016-0437

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


  10 in total

Review 1.  Perioperative considerations for patients treated with bleomycin.

Authors:  M I Waid-Jones; D B Coursin
Journal:  Chest       Date:  1991-04       Impact factor: 9.410

2.  Pulmonary Function in Patients With Germ Cell Cancer Treated With Bleomycin, Etoposide, and Cisplatin.

Authors:  Jakob Lauritsen; Maria Gry Gundgaard Kier; Mikkel Bandak; Mette Saksø Mortensen; Frederik Birkebæk Thomsen; Jann Mortensen; Gedske Daugaard
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

3.  The hazards of anesthesia and surgery in bleomycin-treated patients.

Authors:  P L Goldiner; O Schweizer
Journal:  Semin Oncol       Date:  1979-03       Impact factor: 4.929

4.  The effect of pulmonary function testing on bleomycin dosing in germ cell tumours.

Authors:  F T Roncolato; M Chatfield; B Houghton; G Toner; M Stockler; D Thomson; M Friedlander; H Gurney; M Rosenthal; P Grimison
Journal:  Intern Med J       Date:  2016-08       Impact factor: 2.048

5.  Postoperative acute respiratory distress syndrome in patients with previous exposure to bleomycin.

Authors:  Benjamin M Aakre; Richard I Efem; Gregory A Wilson; Daryl J Kor; John H Eisenach
Journal:  Mayo Clin Proc       Date:  2014-02       Impact factor: 7.616

Review 6.  Bleomycin-induced pneumonitis.

Authors:  S Sleijfer
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

Review 7.  Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.

Authors:  Rafael S Andrade; Kenneth A Kesler; Jamison L Wilson; Jo Ann Brooks; Brett D Reichwage; Karen M Rieger; Lawrence H Einhorn; John W Brown
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

8.  Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.

Authors:  R M Burger; J Peisach; S B Horwitz
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

9.  Bleomycin associated pulmonary toxicity: is perioperative oxygen restriction necessary?

Authors:  S M Donat; D A Levy
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

10.  Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.

Authors:  P L Goldiner; G C Carlon; E Cvitkovic; O Schweizer; W S Howland
Journal:  Br Med J       Date:  1978-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.